Book a demo

Tissue Microarray & Specimen Tracking Patents: Leaders & Gaps 2026

Tissue Microarray & Specimen Tracking Patents: Leaders & Gaps 2026
https://www.patsnap.com/resources/blog/rd-blog/tissue-microarray-and-specimen-tracking-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Patent Landscape · Histopathology Preparation
Tissue Microarray and Specimen Tracking Patents: Who Holds the Core Claims
  • One assignee dominates the ranking. the leader holds 92 records against a fifth-place company at 13 and a tenth-place company at 6, a steep drop rather than a gradual taper.
  • Filing has gone quiet since 2021. the tracked cohort moved from 3 filings in 2021 to 0 in 2024, a -100% swing over that span, though 2025-2026 figures are still filling in.
  • Classification spreads wide, not deep. records span eight IPC subclasses from material analysis (76.7%) to mixing apparatus (48.3%), showing the field borrows heavily from adjacent lab-hardware categories.
Get a prior-art report on your approach
172
Published Records
-100%
Filing Growth 2021→2024
US
Leading Jurisdiction
34
Active Filers Ranked

Filing growth compares 2021 (3 records) with 2024 (0) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field.

Published byPatsnap Research··7 min readSourced from Patsnap Eureka
Overview

What this landscape covers

This review covers 172 published records matching tissue microarray and specimen-tracking search terms — core punch alignment, barcode labelling, cassette printing, chain of custody and archive retrieval — filed or published between 2015 and mid-2026. The scope sits at the intersection of histopathology sample preparation and the logistics hardware and software used to keep specimens identifiable as they move from collection through to slide or block storage.

Records were pulled from receiving offices spanning the United States, Europe, WIPO's PCT route, Australia, India and Israel, giving a reasonably global view of where applicants have chosen to seek protection rather than just where they are based.

Filing activity and technology composition, 2015-2026
  1. 1MONOGEN INC92
  2. 2HOLOGIC INC23
  3. 3VENTANA MEDICAL SYSTEMS INC18
  4. 43M INNOVATIVE PROPERTIES CO14
  5. 5MAYER WILLIAM J13
  6. 6M S MONOGEN10
  7. 7PRESSMAN NORMAN J9
  8. 8WROBLEWSKI LUCIEN J7
  9. 9EISENBERG PETER M6
  10. 10GRUNES MITCHELL B6
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Tissue Microarray and Specimen Tracking covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
The Data

Filing trend and technology composition

Two views of the same 172-record dataset: activity over time, and how records distribute across IPC subclasses. Because a single record can carry several classes, the subclass shares add up to well over 100%.

Filing trend, 2017-2026

Annual filings moved from 2 in 2017 to a peak of 5 in 2025, with 2021 at 3 and 2024 at 0 — a -100% change across that three-year window. Treat 2025 and 2026 as incomplete: publication typically lags filing by around 18 months, so the most recent years will fill in as more records publish.

Filing trend, 2017-2026013452201720182019202020212022202320245202512026Most recent year is partial — publication lag means later filings are not yet visible.

IPC subclass composition

Material analysis and testing (G01N) touches 76.7% of the 172 records, with lab apparatus (B01L) at 65.7% close behind. Packaging, separation and mixing classes each sit in the 48-54% range, indicating that specimen-tracking claims are frequently bundled with general lab-hardware and packaging apparatus rather than filed as a narrow, self-contained category.

IPC subclass compositionG01N · Material analysis & testing13276.7%B01L · Lab apparatus11365.7%B01D · Separation processes (filtrati…9253.5%B65B · Packaging & wrapping9253.5%B67B · Bottle closing & opening9052.3%C12M · Bioreactors & enzyme apparatus8951.7%C12Q · Measuring & testing involving …8951.7%B01F · Mixing & stirring8348.3%Other9555.2%

Shares are the percentage of the 172 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Tissue Microarray and Specimen Tracking covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Tissue Microarray and Specimen Tracking with Eureka

This page is one run against one query. Ask Eureka your own question about tissue microarray and specimen tracking and every answer comes back with the patent numbers behind it.

Try Eureka
Key Patents

Most-cited records in this dataset

Representative Filing
US20110047092A12011-02-24

System and method for tracking and managing transportation of specimens

TAYLOR DATA SYSTEMS, INC.

Filed by Taylor Data Systems, this application describes a courier-facing system where a portable computing device captures specimen identification and location data at pickup and delivery, creating a running record as a specimen moves from a collection site such as a medical office to a processing lab.US20110047092A1 · published 2011-02-24

US20110047092A1 — patent drawing 1US20110047092A1 — patent drawing 2
View full record
Highest-citation records
#Publication no.Patent titleCitations
1US20100063847A1Rule-driven specimen tracking and management93
2US20030092186A1Automated system and method for processing multiple liquid-based specimens87
3US20170320054A1Transporter systems, assemblies and associated methods for transporting tissue samples78
4US6883958B2Apparatus and method for mixing specimens in vials64
5US7284900B2Apparatus and method for mixing specimens in vials63
6US20030099580A1Universal microscope slide cassette63
7US20050195684A1Apparatus and method for mixing specimens in vials58
8US20030089731A1Article dispensing apparatus and method50
9US7572638B2Automated system and method for processing multiple liquid-based specimens48
10US6974294B2Article handling system and method47

Citation counts reward older filings that have had more time to accumulate references — read them as a signal of influence within this searched corpus, not as a ranking of current technical importance.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Tissue Microarray and Specimen Tracking covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis

 
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

What the numbers mean for filing strategy

Three patterns stand out once the ranking, trend and classification data are read together.

Concentration
92 vs. 13
leader vs. fifth place

One assignee, then a steep drop

The leading assignee holds 92 of the ranked records, while fifth place sits at 13 and tenth place at just 6. That gap suggests the leader built a broad portfolio early and the rest of the field is defending narrower positions rather than competing head-on for the same claim space.

Assignee ranking, 34 companies
Momentum
-100%
2021 to 2024

Filing cooled through the early 2020s

The tracked filing count fell from 3 in 2021 to 0 in 2024, a complete drop-off over that span. Recent-year momentum checks on the leading named assignees each show 0 filings in the latest year, consistent with a mature, less contested claim landscape rather than an active filing race.

Filing trend, 2017-2026
Classification spread
8 subclasses
≥48% of records each

Claims sit across lab-hardware categories, not a single niche

From material analysis (76.7%) down to mixing apparatus (48.3%), records are classified across eight IPC subclasses at meaningful share. That spread means a freedom-to-operate check has to clear general lab-apparatus and packaging classes, not just a narrow specimen-tracking code.

IPC composition, 172 records
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to tissue microarray and specimen tracking, with the prior art for and against each one.

Find the white space →
Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Tissue Microarray and Specimen Tracking covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Players

Who holds the ranked positions

The assignee ranking covers 34 companies and individuals across the full 172-record set. It is not a top-50 or top-100 cut — it is the complete list the data endpoint returns for this search.

Leader
92 records
of the ranked total

A single dominant filer

One assignee accounts for 92 records in the ranking, far ahead of any other party tracked here. Co-assignee pairings involving this same organisation and named individual inventors recur among the strongest pairs in the dataset, pointing to a long-running, closely held filing programme.

Assignee ranking
Mid-tier
13 records
fifth place

A thin second tier

Fifth place in the ranking holds 13 records, and tenth place holds just 6 — a fast taper rather than a broad competitive cluster. Newer entrants filing single or double-digit counts sit well below the leader's position.

Assignee ranking
Momentum check
0
latest-year filings, leading names

Quiet activity among top names

Recent-year momentum tracking on the leading named assignees shows 0 filings in the latest year across the board. That is consistent with the broader filing trend cooling after 2021 rather than a single company stepping back.

Recent-year momentum
🔍
Under-claimed sub-areas
Branches that sit below the dominant IPC categories and show room for a first-mover claim.
Automated core-punch registration to digital slide mapsChain-of-custody barcoding across cold-chain handoffsCassette printing tied to LIS record verificationArchive retrieval indexing for paraffin block librariesMisidentification alerts at cross-site specimen transfer
Rank all filers by momentum →
Recent-year filing momentum by assignee
AssigneeRecent yearYoY
MonoGen, Inc.0
Ventana Medical Systems, Inc.0
MAYER WILLIAM J0
3M Innovative Properties Co.0
PRESSMAN NORMAN J0
GRUNES MITCHELL B0
EISENBERG PETER M0
WROBLEWSKI LUCIEN J0
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Tissue Microarray and Specimen Tracking covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's Next

Where to take this analysis

The dataset points to a concentrated ownership structure and a cooling filing rate — both of which change how a freedom-to-operate or whitespace search should be scoped.

Check freedom-to-operate against the leader's full portfolio

With one assignee holding 92 of 172 ranked records, any new filing in core punch alignment or specimen chain-of-custody should be checked directly against that portfolio before drafting claims.

Run a portfolio search in Eureka

Test the under-claimed branches for a first claim

Cassette printing tied to LIS verification and archive retrieval indexing show thinner coverage than the dominant material-analysis and lab-apparatus classes, worth a closer novelty check.

Explore white space in Eureka
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Tissue Microarray and Specimen Tracking covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions about this landscape

Answers are grounded in the same dataset. Derived from a Patsnap search on Tissue Microarray and Specimen Tracking covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Tissue Microarray and Specimen Tracking in depth with Eureka

Go past this page: query the whole tissue microarray and specimen tracking corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.